4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-004048
EVP, Research & CSO sold 10,530 shares at $38.00 ($400,140)
- EVP, Research & CSO acquired 10,530 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-01-15 | Option exercise | +10,530 | $1.53 | $16,111 | 43,730 | D: show line 1 in the form |
| Virgin Herbert EVP, Research & CSO | 2021-01-15 | Sale | −10,530 | $38.00 | $400,140 | 33,200 | D: show line 2 in the form |
| Open-market sales · 10,530 sh · avg $38.00 · $400,140 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-01-15 | Option exercise · Stock Option (Right to Buy) | −10,530 | 411,455 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…